Nada, H., Fikry, S., Hagag, W. (2023). Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy. test, 26(2), 10-16. doi: 10.21608/scumj.2023.298846
Hesham Nada; Sherin Fikry; Wafaa Hagag. "Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy". test, 26, 2, 2023, 10-16. doi: 10.21608/scumj.2023.298846
Nada, H., Fikry, S., Hagag, W. (2023). 'Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy', test, 26(2), pp. 10-16. doi: 10.21608/scumj.2023.298846
Nada, H., Fikry, S., Hagag, W. Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy. test, 2023; 26(2): 10-16. doi: 10.21608/scumj.2023.298846

Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy

Suez Canal University Medical Journal
Article 2, Volume 26, Issue 2, February 2023, Pages 10-16    PDF (257.71 K)
Document Type: Original Article
DOI: 10.21608/scumj.2023.298846
Authors
Hesham Nada* 1; Sherin Fikry1; Wafaa Hagag2
1Dermatology & Venereology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
2Psychiatry Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Abstract
Background: Psoriasis is a chronic inflammatory skin disorder that affects 2-4% of the world’s population, causing psychological, physical, and social impairment. Although the management of psoriasis patients has become increasingly effective, it can only result in a temporary remission of physical symptoms. A challenge to dermatologic care is to achieve a long-lasting remittance of the disease and a substantial improvement in quality of life. Aim: This study aims to assess the quality of life of psoriatic patients and their response to PUVA therapy. Patients and Methods: The study included 36 patients presented with varying degrees of psoriasis. All patients were subjected to full history taking, total skin examination, assessment of psoriasis severity by PASI, and measurement of quality of life (QoL) by QoL inventory (QoLI) both before and 1.5- 2 months after treatment with PUVA. Results:After treatment with PUVA the mean PASI score decreased significantly (P=0.001) from 28.94±11.02 to 22.51±11.66, In addition, the QoLI scores were significantly (P=0.001) elevated from 30.38±19.83 before treatment to 48.58±23.58 after treatment. Conclusion: There was a good effect of PUVA therapy on patients with psoriasis as regards the severity of the disease and quality of life; moreover, the social and psychological aspects should be considered and managed in the management of psoriasis.
 
Keywords
Psoriasis; QoL; PUVA
Statistics
Article View: 167
PDF Download: 350